Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
49.20    0.70 (1.44%)
Bid:
48.85
Ask:
49.55
Spread: 0.70 (1.433%)
Market Cap: £311.37m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Nov 2025 12:30

RNS Number : 4869J
Marston's PLC
28 November 2025
 

28 November 2025

 

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 27 November 2025 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

 

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 27 November 2025, being £0.597 per ordinary share.

 

Awards under the Plan may comprise two elements:

 

(i) a nil-cost option (a "Nil-Cost Option"), and

 

(ii) a CSOP Option over shares with a total value at the date of grant of £60,000 (the statutory limit) with an exercise price of £0.597 per share (a "CSOP Option").

 

The awards will ordinarily vest on the third anniversary of the date of grant to the extent the performance metrics are satisfied. The performance metrics are based on Underlying Profit Before Tax (as regards 40% of the award), Operating Margin (as regards 30% of the award) and Relative Total Shareholder Return (as regards 30% of the award) assessed over the Company's 2026, 2027 and 2028 financial periods, details of which will be set out in the Company's Annual Report and Accounts for the period ended 27 September 2025.

 

To the extent the performance metrics are met, a Nil-Cost Option will be released following a two-year holding period.

 

Linking Arrangement between Nil-Cost Option and CSOP Option

The options granted to Stephen Hopson have been granted such that the maximum pre-tax value delivered to him will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

 

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal released date.

 

Name of individual

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

N/A

1,590,452

Stephen Hopson

Director

100,502

785,175

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Stephen Hopson

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.597 per share and a nil-cost option.

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

785,175

CSOP option: £0.597

100,502

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a nil-cost option.

 

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

1,590,452

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAFPAAPSFFA
Date   Source Headline
3rd Dec 20247:00 amRNSPRELIMINARY RESULTS
16th Oct 20247:00 amRNSCapital Markets Day
9th Oct 20247:00 amRNSTrading update for the 52 weeks to 28 Sep 2024
23rd Sep 20248:58 amRNSHolding(s) in Company
2nd Sep 20243:55 pmRNSHolding(s) in Company
5th Aug 20243:19 pmRNSDirector/PDMR Shareholding
1st Aug 202412:09 pmRNSTotal Voting Rights
31st Jul 202410:41 amRNSCompletion of disposal of 40% stake in Brewing JV
30th Jul 202411:18 amRNSDirector/PDMR Shareholding
25th Jul 20242:50 pmRNSDirector/PDMR Shareholding
24th Jul 20247:00 amRNSTrading Update for the 42 weeks to 20 July 2024
10th Jul 20248:40 amRNSBlock listing Interim Review
8th Jul 20247:00 amRNSDisposal of 40% Stake in Brewing JV
4th Jul 20247:00 amRNSChair Appointment
14th Jun 20244:07 pmRNSHolding(s) in Company
14th May 20247:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 30 MARCH 2024
13th May 20243:42 pmRNSHolding(s) in Company
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.